About Geneoscopy, Inc.
Cancer Prevention | Diagnostics | Precision Medicine
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- St. Louis, MO
- Founded
- 2015
- Company type
- Privately Held
- Company profile name
- Geneoscopy
Geneoscopy Inc. is a life sciences company focused on developing diagnostic tests for gastrointestinal health. Leveraging its proprietary, patented stool-derived eukaryotic RNA (seRNA) biomarker platform, Geneoscopy’s mission is to empower patients and providers to transform gastrointestinal health through innovative diagnostics. The company’s FDA-approved ColoSense™ test uses a proprietary RNA-based platform to screen for colorectal cancer and advanced adenomas for average-risk individuals over the age of 45. In partnership with leading universities and biopharmaceutical companies, Geneoscopy is also developing diagnostic tests for treatment selection and therapy monitoring in other GI disease areas. For more information, visit www.geneoscopy.com and follow the company on LinkedIn.
Specialties
- Life Sciences
- Noninvasive Diagnostic Screening
- Colorectal Cancer Screening
- GI Health
- GI Disease Companion Diagnostics
- seRNA
- RNA Biomarkers
- Precision Medicine Partnerships
- and IBD
Company locations
2220 Welsch Industrial Ct, St. Louis, MO 63146, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 8,866
- People linked to this company
- 72
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.